Kanghong Pharmaceutical: Supervisory Committee\'s Public Explanation and Audit Opinions on the List of Incentives for Stock Value-Added Rights in 2023

SZSI · Dec 16, 2023 00:00

The translation is provided by third-party software.

The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.